Management of GI AEs with ALK Inhibitors

Opinion
Video

Key opinion leaders examine how to manage gastrointestinal side effects in patients on lorlatinib, including preventive tips and comparisons with GI management strategies for other ALK inhibitors.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following:

      • How do you manage gastrointestinal side effects in patients on lorlatinib?
      • Do you provide any preventive tips, and how does this compare to managing GI side effects from other ALK inhibitors?

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Image of a woman with shoulder-length black hair wearing headphones and a white sweater
      Liquid Biopsies Are More Feasible, Appropriate for ESR1+ Breast Cancer
      Image of a woman with a blue background
      Practicing ‘Top of License’ Can Enhance Patient Care, Collaboration
      5 experts in this video
      Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies
      5 experts in this video
      Emerging First-Line Clinical Trials in HER2+ mBC: Insights from HER2CLIMB05, INAVO122, and Other Trials Advancing Precision Medicine
      Image of a man in scrubs with short hair and glasses
      Redeployment Engages Oncology PA Skills, Reduces Burnout
      Photo of a woman with brown hair and bangs, surrounded by a blue border
      Evaluating Options for Second-Line HR+, HER2- Breast Cancer Treatment
      Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights
      Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights
      Quality of Life and Treatment Experience: Patient-Reported Outcomes from TiNivo-2
      Quality of Life and Treatment Experience: Patient-Reported Outcomes from TiNivo-2
      TiNivo-2 Phase 3 Trial: Survival Data and Practical Approaches to Dose Management in Practice
      TiNivo-2 Phase 3 Trial: Survival Data and Practical Approaches to Dose Management in Practice
      Optimizing VEGFR-TKI Therapy: Perspectives on Patient Selection and Management Strategies in Clinic
      Optimizing VEGFR-TKI Therapy: Perspectives on Patient Selection and Management Strategies in Clinic
      Related Content
      Oncology Nurses Provide Patients an Avenue to Supportive Care

      Oncology Nurses Provide Patients an Avenue to Supportive Care

      Diana Martins-Welch, MD
      November 12th 2019
      Article

      Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.

      New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

      New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

      Daniel J. George, MD
      October 3rd 2019
      Article

      For patients with advanced prostate cancer, new findings from the CARD trial could change their daily treatment.

      Adverse Events of CAR T-Cell Therapy

      Adverse Events of CAR T-Cell Therapy

      Sattva S. Neelapu, MD
      July 28th 2019
      Article

      It is crucial for nurses to be aware of adverse events that can occur in patients who are receiving CAR T-cell therapy, explained one expert.

      Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

      Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

      MaryBeth Freeman, MPH
      May 8th 2019
      Article

      After the USPSTF advised against prostate cancer screening for all men, there was a decrease in the incidence of the disease.

      Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

      Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

      Hyman B. Muss, MD
      March 23rd 2016
      Article

      Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.

      Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

      Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

      Kimberly J. Van Zee, MS, MD, FACS
      March 18th 2016
      Article

      Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).